Effect of Central Norepinephrine Depletion on Renovascular Hypertension and on the Renin System

References

• Dargie H. J., Franklin S. S., Reid J. L. The sympathetic nervous system in renovascular hypertension in the rat. (Abstract). Br. J. Pharmacol. 1976; 56: 365
   PubMed Web of Science ®Google Scholar
• Douglas J. R., Jr, Johnson E. M., Jr, Heist J. F., Marshall G. R., Needleman P. Is the peripheral sympathoadrenal nervous system necessary for renal hypertension?. J. Pharmacol. Exp. Ther. 1976; 196: 35–43
   PubMed Web of Science ®Google Scholar
• Grewal R. S., Kaul C. L. Importance of the sympathetic nervous system in the development of renal hypertension in the rat. Br. J. Pharmacol. 1971; 42: 497–501
   PubMed Web of Science ®Google Scholar
• Antonaccio M. J., Ferrone R. A., Waugh M., Harris D., Rubin B. Sympathoadrenal and renin systems in development of two kidney, one clip renal hypertension in rats. Hypertension 1980; 2: 723–731
   PubMed Web of Science ®Google Scholar
• Suzuki H., Saruta T., Ferrario C. M., Brosnihan K. B. Characterization of neurohormonal changes following the production of the benign and malignant phases of two kidney — two clip Goldblatt hypertension. Jpn. Heart J. 1987; 28: 413–426
   PubMedGoogle Scholar
• Mikulic L., Kurnjek M. L., Trolliet M. R., Ruiz P., Basso N., Taquini A. C. Effect of guanethidine on the development of two kidney-two clip renal hypertension. Hypertension 1986; 8(suppl. I)I 123–I 127
   Google Scholar
• Kurnjek M. L., Basso N., Taquini A. C. Neonatal 6-hydroxydopamine treatment and the development of renal hypertension in the rat. Clin. Exp. Hypert. (A) 1984; 6: 1011–1020
   PubMed Web of Science ®Google Scholar
• Suzuki H., Ferrario C. M., Speth R. C., Brosnihan K. B., Smeby R. R., de Silva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension 1983; 5(suppl. I)I 139–I 143
   Google Scholar
• Dargie H. J., Franklin S. S., Reid J. L. Plasma noradrenaline concentration in experimental renovascular hypertension in the rat. Clin. Sci. 1977; 52: 447–453
   Google Scholar
• Petty M. A., Reid J. L. Changes in noradrenaline concentration in brain stem and hypothalamic nuclei during the development of renovascular hypertension. Brain Res. 1977; 136: 376–380
   PubMed Web of Science ®Google Scholar
• Petty M. A., Reid J. L. Brain catecholamines and catecholamine synthesizing enzymes in renovascular hypertension in the rat. Clin. Sci. Mol. Med. 1978; 55: 101 S–104 S
   Google Scholar
• Kostrzewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 1974; 26: 199–288
   PubMed Web of Science ®Google Scholar
• Gordon F. J., Brody M. J., Johnson A. K. Prevention of one kidney (1 K) renal hypertension and associated drinking by central 6-hydroxydopamine. (Abstract). Fed. Proc. 1978; 37: 901
   Google Scholar
• Haeusler G. Vascular reactivity of rats after prevention of hypertension by central administration of 6-hydroxydopamine. J. of Hypert. 1984; 2(suppl. 2)73–75
   PubMedGoogle Scholar
• Basso N., Kurnjek M. L., Mikulic L., Cannata M. A., Taquini A. C. Effect of intracerebroventricular 6-hydroxy- dopamine on the angiotensinogen concentration of the brain. Clin. Exp. Hypert. (A) 1984; 6: 1773–1776
   PubMed Web of Science ®Google Scholar
• Printz M. P., Hawkins R. L., Cleatus J., Mia Chen F. Steroid hormones as feedback regulators of brain angiotensinoqen and catecholamines. Chest 1983; 83 S: 308 S–311 S
   Web of Science ®Google Scholar
• Lewis P. L., Reid J. L., Chalmers J. P., Dollery C. T. Importance of central catecholaminergic neurons in the development and maintenance of renal hypertension. Clin Sci. 1973; 45: 115 S–120 S
   Google Scholar
• Ruiz P., Basso N., Grinspon D., Mangiarua E., Cannata M. A. Angiotensinnogen concentration in cerebrospinal fluid in different experimental conditions in the rat. Hypertension 1983; 5(suppl V)V 29–V 33
   Google Scholar
• Basso N., Kurnjek M. L., de la Riva I. J., Taquini A. C. Renin-like activity in the rat brain: distribution in normal and renovascular hypertensive animals. Hypertension, H. Villarreal. John Wiley & Sons, New York 1981; 59–67
   Google Scholar
• Haber E., Koerner T., Page L. T., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal subjects. J. Clin. Endocrinol. 1969; 29: 1349–1355
   PubMed Web of Science ®Google Scholar
• Laverty R., Taylor K. M. The fluorimetric assay of catecholamines and related compounds: improvements and extensions to the hydroxyndole technique. Anal. Biochem. 1968; 22: 269–279
   PubMed Web of Science ®Google Scholar
• Finch L., Haeusler G., Thoenen H. Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine. Brit. J. Pharmacol. 1972; 44: 356 P–357 P
   Google Scholar
• Erinoff L., Heller A., Oparil S. Central catecholamine depletion and the prevention of hypertension. (Abstract). Fed Proc. 1975; 34: 817
   Google Scholar
• Reid J. L., Zivin J. A., Kopin I. J. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ. Res. 1975; 37: 569–579
   PubMed Web of Science ®Google Scholar
• Dargie H. J., Franklin S. S., Reid J. L. Central and peripheral noradrenaline in the two kidney model of renovascular hypertension in the rat. Br. J. Pharmacol. 1977; 61: 213–215
   PubMed Web of Science ®Google Scholar
• Montastruc J. L., Montastruc P. Effect of intracisternal application of 6-hydroxydopmine on the antihypertensive action of propranolol in the dog. European J. Pharmacol. 1980; 63: 103–116
   PubMed Web of Science ®Google Scholar
• Kurnjek M. L., Basso N., Mikulic L., Taquini A. C. Effect of ketanserin and prazosin on blood pressure and cardiovascular reactivity to vasopressor agents during the development of two kidney — two clip renal hypertension in the conscious rat. Arch. Internal. Physiol. Bioch. 1989; 97: 59–64
   PubMed Web of Science ®Google Scholar
• Lynch K. R., Simnad V. I., Ben Ari E. T., Garrison J. C. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension 1986; 8: 540–543
   PubMed Web of Science ®Google Scholar
• Campbell D. J., Habener J. F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 1986; 78: 31–39
   PubMed Web of Science ®Google Scholar
• Schelling P, Liard J. F., Felix D. Regulation of brain angiotensinogen in renal hypertensive rats. Clin. Exp. Hypert. (A) 1984; 6: 1755–1759
   PubMed Web of Science ®Google Scholar
• Hellmann W., Takahashi S., Athanasio G., Lindpaintner K., Nakanishi S., Ganten D. Angiotensinogen gene expression in normotensive and hypertensive rats. (Abstract). Clin. Exp. Hypert. (A) 1989; 11: 678
   Google Scholar
• Printz M. P. Regulation of the brain angiotensin system: a thesis of multicellular involvement. Clin. Exp. Hyper. (A) 1988; 10: 17–35
   PubMed Web of Science ®Google Scholar
• Ferrario C. M., Mohara O., Ueno Y., Brosnihan K. B. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. Am. J. Med. Sci. 1988; 295: 352–359
   PubMed Web of Science ®Google Scholar
• Hermann K, Ganten D., Bayer C., Unger T., Lang R. E., Rascher W. Definitive evidence for the presence of [Ile5]-angiotensin I and [Ile5]-angiotensin II in the brain of rats. Scholkens The Renin Angiotensin System in the Brain, D. Ganten, M. P. Printz, M. I.B.A. Phillips. Springer-Verlag, Berlin, Heidelberg, New York 1982; 192–207
   Google Scholar
• Basso N., Ruiz P., Kurnjek M. L., Cannata M. A., Taquini A. C. The brain renin-angiotensin system and the development of DOC-salt hypertension. Clin. Exper. Hypert. (A) 1985; 7: 1259–1268
   PubMed Web of Science ®Google Scholar